Use of emergency department transcranial Doppler assessment of reperfusion after intravenous tPA for ischemic stroke.

TitleUse of emergency department transcranial Doppler assessment of reperfusion after intravenous tPA for ischemic stroke.
Publication TypeJournal Article
Year of Publication2012
AuthorsPhillips S, Stanley L, Nicoletto H, Burkman M, Laskowitz DT, Cairns CB
JournalJ Emerg Med
Volume42
Issue1
Pagination40-3
Date Published2012 Jan
ISSN0736-4679
KeywordsAged, Brain Ischemia, Cerebrovascular Circulation, Emergency Service, Hospital, Fibrinolytic Agents, Humans, Infarction, Middle Cerebral Artery, Infusions, Intra-Arterial, Male, Reperfusion, Tissue Plasminogen Activator, Treatment Failure, Ultrasonography, Doppler, Transcranial
Abstract

BACKGROUND: Thrombolysis with intravenous recombinant tissue plasminogen activator (IV-tPA) has been associated with significant improvements in clinical outcomes when initiated within 3 h of symptom onset. Although adjunctive therapies for acute stroke have been developed, challenges remain in identifying appropriate patients and therapeutic end-point measurements.

OBJECTIVE: To describe the use of transcranial Doppler (TCD) monitoring in the Emergency Department (ED) to guide the decision for advanced reperfusion strategies after failure of IV-tPA.

CASE REPORT: A 75-year-old man presented to the ED within 50 min after the acute onset of right-sided hemiparesis and aphasia. After administration of IV-tPA, there was no immediate improvement in neurological symptoms. TCD performed in the ED demonstrated persistent left middle cerebral artery (MCA) occlusion. Based on this information, the patient received intra-arterial tPA followed by mechanical thrombectomy of the MCA occlusion, resulting in clinical improvement of the patient's right hemiparesis and aphasia.

CONCLUSION: TCD is a feasible assessment tool for use in the ED to aid in diagnosis and to guide treatment decisions in patients with acute ischemic stroke, including those not responding to IV-tPA therapy.

DOI10.1016/j.jemermed.2008.06.028
Alternate JournalJ Emerg Med
PubMed ID19111426